Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Trends Genet. 2013 May;29(5):290-7. doi: 10.1016/j.tig.2012.12.004. Epub 2013 Jan 18.
Cohesins are mutated in a significant number of tumors of various types making them attractive targets for chemotherapeutic intervention. However, cohesins have a spectrum of cellular roles including sister chromatid cohesion, transcription, replication, and repair. Which of these roles are central to cancer biology and which roles can be exploited for therapeutic intervention? Genetic interaction networks in yeast have identified synthetic lethal interactions between mutations in cohesin and replication fork mediators. These interactions are conserved in worms and in human cells suggesting that inhibition of replication fork stability mediators such as poly (ADP-ribose) polymerase (PARP) could result in the specific killing of tumors with cohesin mutations. These findings also highlight the utility of genetic interaction networks in model organisms for the identification of clinically relevant interactions. Here, we review this type of approach, emphasizing the power of synthetic lethal interactions to reveal new avenues for developing cancer therapeutics.
黏连蛋白在各种类型的肿瘤中发生大量突变,这使其成为化疗干预的有吸引力的靶点。然而,黏连蛋白具有一系列细胞功能,包括姐妹染色单体黏合、转录、复制和修复。这些功能中哪些对癌症生物学至关重要,哪些功能可以被用于治疗干预?酵母中的遗传相互作用网络已经确定了黏连蛋白突变和复制叉介质之间的合成致死相互作用。这些相互作用在蠕虫和人类细胞中是保守的,这表明抑制复制叉稳定性介质,如多聚(ADP-核糖)聚合酶(PARP),可能导致黏连蛋白突变的肿瘤的特异性杀伤。这些发现还突出了遗传相互作用网络在模型生物中的应用,用于鉴定临床上相关的相互作用。在这里,我们综述了这种方法,强调了合成致死相互作用揭示开发癌症治疗方法的新途径的力量。